<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04634656</url>
  </required_header>
  <id_info>
    <org_study_id>SM 2020</org_study_id>
    <nct_id>NCT04634656</nct_id>
  </id_info>
  <brief_title>Lidocaine on Early Cognitive Dysfunction in Shoulder Arthroscopy</brief_title>
  <official_title>Neuroprotective Effects of Lidocaine on Early Postoperative Cognitive Dysfunction in Patients Undergoing Shoulder Arthroscopy With Beach Chair Position: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The beach chair position (BCP) combined with deliberate hypotension impair cerebral perfusion&#xD;
      pressure and oxygenation during arthroscopic shoulder surgeries and produce cerebral&#xD;
      ischemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic diagnosis and treatment of shoulder disorders have replaced open procedure as&#xD;
      the primary treatment method. The beach chair (BCP) and lateral decubitus (LDP) positions are&#xD;
      both considered as reliable techniques for performing effective arthroscopic shoulder&#xD;
      surgeries. The usage of BCP for shoulder arthroscopic operations started from early 1980s.&#xD;
&#xD;
      The advantages of BCP include lack of brachial plexus strain, good intra-articular&#xD;
      visualization, with the ease of conversion to an open approach if required.&#xD;
&#xD;
      The BCP combined with deliberate hypotension has been used to decrease intraoperative blood&#xD;
      loss and allow a relatively blood-free surgical field. However, this combination has the risk&#xD;
      to impair cerebral perfusion pressure and oxygenation during surgery and produce cerebral&#xD;
      ischemia.&#xD;
&#xD;
      Lidocaine, a commonly used local anesthetic and class IB antiarrhythmic drug, that readily&#xD;
      crosses the blood - brain barrier. Evans et al. initially reported cerebral protection of&#xD;
      lidocaine in a feline model of cerebral arterial gas embolism. Later on, the effects of&#xD;
      lidocaine on perioperative neuroprotection were detected. However, the mechanisms underlying&#xD;
      lidocaine treatment-induced neuroprotection remain incompletely understood.&#xD;
&#xD;
      Lidocaine may provide cerebral protection through many mechanisms, including decreasing the&#xD;
      cerebral metabolic rate, decelerating the ischemic transmembrane ion shift, and reducing the&#xD;
      ischemic excitotoxin release.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2021</start_date>
  <completion_date type="Anticipated">November 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 10, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative cognitive function</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Assessed using Mini-Mental State Examination (MMSE) test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cognitive Dysfunction, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive lidocaine in a loading dose of 1 mg/ kg diluted in 10 ml of normal saline that will be infused over 5 minutes after induction of anesthesia then followed by a continuous infusion at 1.5 mg/ kg/ h diluted in normal saline to a volume of 50 ml until the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive normal saline after induction of anesthesia with the same volume and rate changes as lidocaine group until the end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Patients will receive lidocaine in a loading dose of 1 mg/ kg diluted in 10 ml of normal saline that will be infused over 5 minutes after induction of anesthesia then followed by a continuous infusion at 1.5 mg/ kg/ h diluted in normal saline to a volume of 50 ml until the end of surgery</description>
    <arm_group_label>Group L</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Patients will receive normal saline after induction of anesthesia with the same volume and rate changes as lidocaine group until the end of surgery</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing elective arthroscopic shoulder surgery under general anesthesia in&#xD;
             beach chair position (BCP),&#xD;
&#xD;
          -  Age 20 to 65 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mini-Mental State Examination (MMSE) score &lt; 23 before surgery&#xD;
&#xD;
          -  History of neurological disease (such as previous episodes of cerebral ischemia or&#xD;
             stroke).&#xD;
&#xD;
          -  History of psychological disorder&#xD;
&#xD;
          -  Suspected history of adverse reactions to lidocaine&#xD;
&#xD;
          -  Drug or alcohol abuse&#xD;
&#xD;
          -  History of diabetes mellitus, sever hypertension, severe anemia, hepatic or renal&#xD;
             dysfunction&#xD;
&#xD;
          -  Unwillingness to comply with protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seham M Moeen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seham M Moeen, MD</last_name>
    <phone>01006386324</phone>
    <phone_ext>02</phone_ext>
    <email>seham.moeen@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seham Mohamed Moeen</name>
      <address>
        <city>Assiut</city>
        <state>Asyut</state>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seham M Moeen, MD</last_name>
      <phone>01006386324</phone>
      <phone_ext>02</phone_ext>
      <email>seham.moeen@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Seham Mohamed Moeen Ibrahim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Cognitive Complications</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

